Orchestra BioMed Holdings, Inc. (OBIO) Net income 2021–2025
Orchestra BioMed Holdings, Inc. (OBIO) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
-$52.7MFY2025 · since FY2021: -$378,753 → -$52.7M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$52.7M | +13.6% |
| FY2024 | -$61.0M | -24.2% |
| FY2023 | -$49.1M | -46.2% |
| FY2022 | -$33.6M | -8773.3% |
| FY2021 | -$378,753 | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More OBIO financial trends
OBIO RevenueOBIO Net marginOBIO Gross profitOBIO Gross marginOBIO Operating incomeOBIO Operating marginOBIO Operating cash flowOBIO Free cash flowOBIO Capital expendituresOBIO Return on equityOBIO Stock buybacksOBIO Dividends paidOBIO Total assetsOBIO Total liabilitiesOBIO Shareholders’ equityOBIO overview →